Anebulo Pharmaceuticals (ANEB) Financials

$0.36

$0.03 (8.60%)

As on 15-Sep-2026 16:00EDT

Market cap

$14 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	9.10	9.22	8.31	11.78	11.78	6.83
Operating Profit (EBIT)	-9.10	-9.22	-8.31	-11.78	-11.78	-6.83
Other Income	--	--	--	--	--	--
Profit before Tax	-7.98	-8.48	-8.20	-11.73	-11.73	-6.83
Provision for Tax	--	--	--	-0.10	-0.10	--
Profit after Tax (Net Income)	-7.98	-8.48	-8.20	-11.73	-11.73	-6.83
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-11.73

Liabilities ($ Mln)	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Shareholder's Funds	7.94	11.66	3.81	10.60	10.60	15.07
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.93	0.26	--	0.53	--	--
Current Liabilities	0.55	0.22	0.26	0.53	1.07	0.51
Total Liabilities	9.98	12.15	4.07	11.67	11.67	15.58

Assets ($ Mln)	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Non-Current Assets	0.15	0.18	0.57	--	--	--
Current Assets	9.27	11.96	3.51	11.25	11.67	15.58
Total Assets	10.91	12.15	4.07	11.67	11.67	15.58
Total Debt*	--	--	--	--	--	--
Net Current Assets	7.79	11.47	3.25	--	10.60	10.60

Cashflow ($ Mln)	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Cash From Operating Activities	--	-6.35	-8.09	-9.68	-9.68	-5.44
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	14.88	-0.06	6.38	6.38	6.38
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Adjusted EPS ($)	-0.21	-0.21	-0.32	-0.45	-0.47	-0.26
Cash EPS ($)	--	-0.21	-0.32	-0.45	-0.47	-0.26
Adjusted Book Value ($)	--	0.28	0.15	0.41	0.42	0.58
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.15	-0.31	-0.37	-0.39	-0.21
Free Cash Flow per Share ($)	--	-0.15	-0.31	-0.37	-0.39	-0.21

Profitability Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
ROCE (%)	--	-109.69	-113.81	-91.42	-91.42	-37.42
ROE (%)	-81.44	-109.69	-113.81	-91.42	-91.42	-37.42
ROA (%)	-57.76	-104.63	-104.20	-86.11	-86.11	-36.66
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	52.39	-0.66	31.68	--	-72.64	-226.08
Net Profit Growth (%)	-4.06	-3.45	30.09	-71.89	-71.89	77.45
EPS Growth (%)	26.21	0.35	0.32	-0.72	-0.60	0.80
Book Value Growth (%)	-64.61	--	--	--	--	--

Valuation Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Price / Earnings	--	-6.97	-8.59	-5.36	-5.02	-9.23
Price / Book Value	1.70	5.07	18.49	5.94	5.56	4.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.54	-6.16	-8.65	-4.39	-4.05	-7.11
Close Price ($)	1.01	1.44	2.73	2.42	2.35	2.42
High Price ($)	3.42	3.08	4.05	4.05	7.00	7.89
Low Price ($)	0.90	0.80	1.62	1.62	1.77	1.77
Market Cap ($ Cr)	13.54	--	--	--	--	--

Solvency Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	16.71	53.36	13.46	21.04	10.92	30.40
Quick Ratio	16.71	--	--	--	--	--
Interest Coverage	-25.82	-21.21	-53.23	--	--	-1,607.15

Operating Efficiency Ratios	TTM	Jun-25	Jun-24	Dec-23	Jun-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.